Elixirr International PLC
LSE:ELIX

Watchlist Manager
Elixirr International PLC Logo
Elixirr International PLC
LSE:ELIX
Watchlist
Price: 730 GBX 1.39% Market Closed
Market Cap: 349m GBX
Have any thoughts about
Elixirr International PLC?
Write Note
Section:
 

Relative Value

The Relative Value of one ELIX stock under the Base Case scenario is 747.56 GBX. Compared to the current market price of 730 GBX, Elixirr International PLC is Undervalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ELIX Relative Value
Base Case
747.56 GBX
Undervaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4
P/S
P/S
Price to Sales
4
vs History
18
vs Industry
23
Median 3Y
3.4
Median 5Y
3.1
Industry
1.3
Forward
3.1
More Details
20
P/E
P/E
Price to Earnings
20
vs History
22
vs Industry
45
Median 3Y
18.3
Median 5Y
16.2
Industry
19
Forward
17.3
More Details
20.6
P/OCF
P/OCF
Price to OCF
20.6
vs History
18
vs Industry
30
Median 3Y
16.6
Median 5Y
15
Industry
13.4
More Details
27.6
P/FCFE
P/FCFE
Price to FCFE
27.6
vs History
22
vs Industry
29
Median 3Y
23.2
Median 5Y
21.2
Industry
18.3
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
33
vs Industry
46
Median 3Y
2.5
Median 5Y
2.5
Industry
2.4
More Details
3.9
EV/S
EV/S
Enterprise Value to Sales
3.9
vs History
22
vs Industry
24
Median 3Y
3.1
Median 5Y
2.9
Industry
1.3
Forward
3
More Details
11.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.3
vs History
22
vs Industry
17
Median 3Y
9.6
Median 5Y
8.7
Industry
3.3
More Details
14.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.1
vs History
20
vs Industry
39
Median 3Y
11.6
Median 5Y
10.8
Industry
10.4
Forward
10.8
More Details
16
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16
vs History
22
vs Industry
40
Median 3Y
13.5
Median 5Y
12.4
Industry
12.7
Forward
12.5
More Details
19.7
EV/OCF
EV/OCF
Enterprise Value to OCF
19.7
vs History
16
vs Industry
28
Median 3Y
15.7
Median 5Y
14
Industry
12.6
More Details
19.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.9
vs History
18
vs Industry
29
Median 3Y
15.9
Median 5Y
14.3
Industry
14.7
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
27
vs Industry
36
Median 3Y
2.3
Median 5Y
2.3
Industry
1.7
More Details

Multiples Across Competitors

ELIX Competitors Multiples
Elixirr International PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Elixirr International PLC
LSE:ELIX
345.5m GBP 4 20 14.1 16
UK
Relx PLC
LSE:REL
67.4B GBP 7.2 35.6 20.4 26.2
CA
Thomson Reuters Corp
TSX:TRI
105.3B CAD 10.2 32 26.9 38
UK
IHS Markit Ltd
F:0M3
37.9B EUR 8.5 32.7 24.3 36.4
IE
Experian PLC
LSE:EXPN
31.8B GBP 5.6 33.3 146.1 206.4
NL
Wolters Kluwer NV
AEX:WKL
37.9B EUR 6.6 36.5 22.1 29.4
US
Verisk Analytics Inc
NASDAQ:VRSK
39.4B USD 14 42.7 27.6 34.9
US
Equifax Inc
NYSE:EFX
32.4B USD 5.8 57.5 22 36.7
US
CoStar Group Inc
NASDAQ:CSGP
29.9B USD 11.2 170.3 152.2 759.8
US
Leidos Holdings Inc
NYSE:LDOS
19.4B USD 1.2 16.2 10.8 12.7
CH
SGS SA
SIX:SGSN
17.1B CHF 2.6 31.3 22.8 22.8
P/E Multiple
Earnings Growth P/E to Growth
UK
Elixirr International PLC
LSE:ELIX
Average P/E: 46.2
20
50%
0.4
UK
Relx PLC
LSE:REL
35.6
55%
0.6
CA
Thomson Reuters Corp
TSX:TRI
32
-23%
N/A
UK
I
IHS Markit Ltd
F:0M3
32.7
N/A N/A
IE
Experian PLC
LSE:EXPN
33.3
54%
0.6
NL
Wolters Kluwer NV
AEX:WKL
36.5
35%
1
US
Verisk Analytics Inc
NASDAQ:VRSK
42.7
90%
0.5
US
Equifax Inc
NYSE:EFX
57.5
163%
0.4
US
CoStar Group Inc
NASDAQ:CSGP
170.3
100%
1.7
US
Leidos Holdings Inc
NYSE:LDOS
16.2
683%
0
CH
SGS SA
SIX:SGSN
31.3
49%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Elixirr International PLC
LSE:ELIX
Average EV/EBITDA: 44.5
14.1
77%
0.2
UK
Relx PLC
LSE:REL
20.4
27%
0.8
CA
Thomson Reuters Corp
TSX:TRI
26.9
22%
1.2
UK
I
IHS Markit Ltd
F:0M3
24.3
N/A N/A
IE
Experian PLC
LSE:EXPN
146.1
33%
4.4
NL
Wolters Kluwer NV
AEX:WKL
22.1
27%
0.8
US
Verisk Analytics Inc
NASDAQ:VRSK
27.6
34%
0.8
US
Equifax Inc
NYSE:EFX
22
67%
0.3
US
CoStar Group Inc
NASDAQ:CSGP
152.2
123%
1.2
US
Leidos Holdings Inc
NYSE:LDOS
10.8
40%
0.3
CH
SGS SA
SIX:SGSN
22.8
30%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Elixirr International PLC
LSE:ELIX
Average EV/EBIT: 110.8
16
73%
0.2
UK
Relx PLC
LSE:REL
26.2
42%
0.6
CA
Thomson Reuters Corp
TSX:TRI
38
27%
1.4
UK
I
IHS Markit Ltd
F:0M3
36.4
N/A N/A
IE
Experian PLC
LSE:EXPN
206.4
52%
4
NL
Wolters Kluwer NV
AEX:WKL
29.4
36%
0.8
US
Verisk Analytics Inc
NASDAQ:VRSK
34.9
38%
0.9
US
Equifax Inc
NYSE:EFX
36.7
105%
0.3
US
CoStar Group Inc
NASDAQ:CSGP
759.8
126%
6
US
Leidos Holdings Inc
NYSE:LDOS
12.7
63%
0.2
CH
SGS SA
SIX:SGSN
22.8
37%
0.6

See Also

Summary
ELIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ELIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ELIX stock valuation using valuation multiples.
Wall Street Estimates
ELIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ELIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.